Dr. Edmund Y. Ting Ph.D., Sc.D. Ph.D. Net Worth

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Dr D PBIO stock SEC Form 4 insiders trading

Dr has made over 1 trades of the Pressure BioSciences stock since 2006, according to the Form 4 filled with the SEC. Most recently he bought 2,000 units of PBIO stock worth 6,100$ on 29 August 2006.

The largest trade he's ever made was buying 2,000 units of Pressure BioSciences stock on 29 August 2006 worth over 6,100$. On average, Dr trades about 74 units every 0 days since 2006.

You can see the complete history of Dr Ting stock trades at the bottom of the page.

Dr. Edmund Y. Ting Ph.D., Sc.D. Ph.D. biography

Dr. Edmund Y. Ting Ph.D., Sc.D. Ph.D. is the Sr. VP of Engineering at Pressure BioSciences.

What is the salary of Dr D?

As the Sr. VP of Engineering of Pressure BioSciences, the total compensation of Dr D at Pressure BioSciences is 218,747$. There are 2 executives at Pressure BioSciences getting paid more, with Richard Schumacher having the highest compensation of 357,263$.

How old is Dr D?

Dr D is 66, he's been the Sr. VP of Engineering of Pressure BioSciences since . There are 4 older and 3 younger executives at Pressure BioSciences. The oldest executive at Pressure BioSciences, Inc. is Richard T. Schumacher, 71, who is the Founder, Pres, CEO, Treasurer, Interim CFO, Clerk & Director.

What's Dr D's mailing address?

Edmund's mailing address filed with the SEC is 23642 123rd Pl SE, Kent, WA 98031, USA.

Insiders trading at Pressure BioSciences

Over the last 21 years, insiders at Pressure BioSciences have traded over 0$ worth of Pressure BioSciences stock and bought 433,961 units worth 321,010$ . The most active insiders traders include Gregory Gene Freitag、Richard T Schumacher、Kevin W Quinlan. On average, Pressure BioSciences executives and independent directors trade stock every 111 days with the average trade being worth of 342$. The most recent stock trade was executed by Bradford Addison Young on 31 December 2018, trading 1,579 units of PBIO stock currently worth 3,553$.

What does Pressure BioSciences do?

Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the Americas, Europe, Asia, Africa, and Australia. Its pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. The company offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and The Shredder SG3. It also distributes cell disruption equipment, parts, and consumables. In addition, the company offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. It serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. Pressure BioSciences, Inc. has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. Pressure BioSciences, Inc. was incorporated in 1978 and is based in South Easton, Massachusetts.

Complete history of Dr Ting stock trades at Pressure BioSciences

Pressure BioSciences executives and stock owners

Pressure BioSciences executives and other stock owners filed with the SEC include:

• Richard Schumacher,
  Director
• Richard T. Schumacher,
  Founder, Pres, CEO, Treasurer, Interim CFO, Clerk & Director
• Dr. Edmund Y. Ting Ph.D., Sc.D. Ph.D.,
  Sr. VP of Engineering
• Dr. Alexander V. Lazarev,
  Chief Science Officer
• Daniel Shea,
  Chief Financial Officer
• Michael Urdea,
  Independent Director
• Kevin Pollack,
  Independent Director
• Vito Mangiardi,
  Independent Director
• Jeffery Peterson,
  Independent Chairman of the Board
• John B. Hollister,
  Director of Sales & Marketing
• Alexander V Lazarev,
  Director
• Bradford Addison Young,
  Chief Commerical Officer
• Jeffrey N Peterson,
  Director
• Richard Thomley,
  Chief Financial Officer
• Joseph Luis Jr Damasio,
  VP of Finance
• Calvin Albert Saravis,
  Director
• Matthew B Potter,
  Vice President of Sales
• Steven E Hebert,
  CFO / VP Finance / Asst. Treas
• J Donald Payne,
  Director
• Edward H Myles,
  Vice President of Finance/CFO
• Edmund Y Ting,
  Senior VP of Engineering
• Kevin W Quinlan,
  Director
• P Thomas Vogel,
  Director
• R Wayne Fritzsche,
  Director
• Alan D Rosenson,
  Director
• Nathan Lawrence,
  VP of Marketing and Sales
• Gregory Gene Freitag,
  Director
• Clayton Acss Llc/Il Struve,
  
• Alan Ira Goldberg,
  Director